Been buying BXLC around $11; Q3 EPS $.69 vs $.43; trailing 12-month EPS now $1.91; book value is $21.27/share of very liquid assets, primarily a large stake in closed-end fund DNI.
All financials are linked here:
Bexil Corporation Announces Third Quarter 2017 Financial Results
NEW YORK, NY / ACCESSWIRE / November 9, 2017 / Bexil Corporation (OTC PINK: BXLC) today reported its financial results for the third quarter ended September 30, 2017.
For the three months ended September 30, 2017, Bexil recorded net income attributable to Bexil shareholders of approximately $0.6 million, or $0.69 of diluted earnings per share, compared to net income attributable to Bexil shareholders of approximately $0.4 million, or $0.43 of diluted earnings per share, for the three months ended September 30, 2016.
For the nine months ended September 30, 2017, Bexil recorded net income attributable to Bexil shareholders of approximately $1.4 million, or $1.45 of diluted earnings per share, compared to net income attributable to Bexil shareholders of approximately $0.5 million, or $0.52 of diluted earnings per share, for the nine months ended September 30, 2016.
The Companys book value per share attributable to Bexil shareholders at September 30, 2017 was $21.27, based on shareholders equity attributable to Bexil shareholders of $19,059,037 and 895,903 shares issued and outstanding.
The Companys unaudited balance sheet, statements of comprehensive income, and statements of cash flows as of and for the nine months ended September 30, 2017 are appended to the copy of this press release on www.Bexil.com.
About Bexil Corporation
Bexil is a holding company engaged through subsidiaries in investment management and securities trading as a market intermediary. To learn more about Bexil, including Rule 15c2-11 information, please visit www.Bexil.com.
Safe Harbor Note
This release contains certain "forward-looking statements" made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors, many of which are beyond the control of Bexil, which may cause the Companys actual results to be materially different from those expressed or implied by such statements. Investors should carefully consider the risks, uncertainties and other factors, together with all of the other information included in the Company’s Annual Report, at http://www.bexil.com/cautionary-language.html, and similar information. The forward-looking statements made herein are only made as of the date of this release, and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.
The Company views book value per share, a non-GAAP financial measure, as an important indicator of financial performance. Presented in conjunction with other financial information, the combined presentation can enhance an investors understanding of the Companys underlying financial condition and results from operations. The definition of book value as presented in this press release is shareholders’ equity attributable to Bexil shareholders divided by currently issued and outstanding shares.
Chief Financial Officer
1-212-785-0900, ext. 267
SOURCE: Bexil Corporation